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We report that Pseudomonas aeruginosa bacteriophages can be consistently recovered from the sputum of patients with chronic P. aeruginosa bronchopulmonary infections. Although it is generally appreciated that P. aeruginosa phages can be isolated from natural sources such as seawater and sewage (5) in which P. aeruginosa can be found, the presence of phage at the sites of Pseudomonas infection in humans is not widely recognized. We present a preliminary characterization of several purified P. aeruginosa phages isolated from the sputum of seven cystic fibrosis (CF) patients and one non-CF individual.
Sputum was collected from CF inpatients at the clinical center and from a tracheostomized non-CF individual with metastatic adenocarcinoma whose bronchopulmonary tract had been colonized with P. aeruginosa. About 1 ml of sputum was dispersed into 7 ml of a buffer containing 1 M NaCl, 10 mM Tris-hydrochloride (pH 8.0), 15 mM P-mercaptoethanol, and 0.1 mM phenylmethylsulfonyl fluoride. A small sample was plated on Trypticase (BBL Microbiology Systems) to determine the concentration of viable P. aeruginosa, and the remainder was centrifuged at 10,000 x g for 30 min to remove bacteria and insoluble material. The clear supernatant fraction was then spun at 100,000 x g for 8 to 12 h to pellet the bacteriophage. The fluid overlying the small pellet was carefully removed, and the pellet was resuspended in 0.5 ml of 0.1 M NaCl-10 mM MgSO4-50 mM Trishydrochloride (pH 8.0)-0.01% gelatin. Phages were assayed either by spotting dilutions of the suspended pellet onto lawns of P. aeruginosa indicator strains or by the soft agar overlay technique (1) , with the same indicator strains. P. aeruginosa strains included PAO (5) , PAT (5) , and H29, all kindly provided by L. Nakamura (Northern Regional Research Center, Peoria, Ill.); ATCC 52533, obtained from the American Type Culture Collection (Rockville, Md.); and 11 strains isolated in our laboratory from the sputum of CF patients. Titers of phage-neutralizing antibodies were determined from sera of patients as described by Adams (1). To determine if a particular bacterial strain was lysogenic, broth cultures, started from isolated single bacterial colonies, were assayed for phage after induction with 2 ,ug of mitomycin C per ml (6) . Phage stocks were prepared from single plaques grown on strain PAT (except CF14, grown on H29) in a soft agar layer and further propagated in broth culture. Phages were concentrated by centrifugation and purified on a cesium chloride gradient (7) .
Phages were detected in each of the sputum samples collected from eight patients with bronchopulmonary P. aeruginosa infection. P. aeruginosa was present in each sputum sample analyzed at concentrations ranging between 105 and 107 bacteria per ml. Different phages within a sputum sample were initially distinguished on lawns of P. aeruginosa strains PAT or H29 by plaque morphology. Each sputum sample contained at least one phage strain, with one sample harboring at least four ( Table 1 ). The phage concentrations in sputum ranged from 103 to 107 plaque-forming units per ml (with the mean about 104 plaque-forming units per ml). P. aeruginosa phages could not be detected in the sputum from individuals who did not have bronchopulmonary P. aeruginosa infection (two with asthma, two with chronic bronchitis).
Of the 16 phages isolated, 12 exhibited unique host range patterns on the battery of 16 P. aeruginosa strains (Table 1) . By electron microscopic examination, each phage was shown to have a polyhedral head of about 55 nm in diameter and a tail structure, either shorter, longer, or equal to the longest head dimension. Their structures are similar to those of previously described temperate phages, which are active on P. aeruginosa and isolated from sewage (3, 4) .
The sera of several patients were assayed for the presence of neutralizing antibodies to the phages isolated from their various sputa and assayed 6 months after the initial isolation of the phage. In no case could antiphage activity be detected, even in one patient's serum assayed 6 months after the initial isolation of the phage.
Each P. aeruginosa isolate from a given patient appeared to be lysogenized by at least one phage, since phage induction could be demonstrated after the addition of mitomycin C to broth cultures of these bacteria. In several cases one or more of the mitomycin C-induced phages resembled, with respect to host range, plaque morphology, and electron microscopic structure, the viruses isolated directly from the same sputum sample from which the lysogenic bacterial strains had been recovered. It should be noted that most of the 16 phage isolates collected in this study were capable of lysogenizing at least one of the bacterial indicator strains tested.
In summary, we have shown that bacteriophages that are active on P. aeruginosa are present in the sputum of patients harboring large numbers of P. aeruginosa. In five of the eight patients, multiple phage strains were isolated from the same sputum sample, and altogether, at least 12 different phage strains were isolated from this clinical population. Although the precise mechanism by which phages arise in sputum is not yet defined, the most common source of bacteriopha,ges in natural infections is lysogenic bacteria (2) . Since almost all clinical P. aeruginosa isolates are lysogenized by one or more phages (5), a property observed in the bacterial strains collected from the patients described in this report, we assume that phages in sputum have lysogenic P. aeruginosa as their primary source. The extent to which phages contribute to the pathogenicity of P. aeruginosa in humans awaits a detailed analysis of the effects of bacteriophages on P. aeruginosa aIld the extent to which such effects modify the course of infection by that bacterium.
